← Open Payments lookup

REBECCA POWELL: Open Payments

NPI 1770258790 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$734 in 16 payments from 11 companies in 2025. Trend: 2023 $579 · 2024 $341 · 2025 $734

Food & beverage: $734
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$160
Teva Pharmaceuticals USA, Inc.2$141
Luye Pharma (USA) Ltd.1$129
Axsome Therapeutics, Inc.1$106
ABBVIE INC.2$63
Collegium Pharmaceutical, Inc.2$33
Alkermes, Inc.1$28
Supernus Pharmaceuticals, Inc.1$21
Otsuka America Pharmaceutical, Inc.1$20
Neurocrine BioSciences, Inc.1$17

Products named: CAPLYTA, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE, Auvelity, VRAYLAR, REXULTI, Jornay PM, ARISTADA.

Industry payments across KY — which companies pay providers there.